The Supreme Court today is hearing the case of FDA v. Wages and White Lion Investments, which focuses on FDA's regulation of ecigarettes.
But as I explained in early September, the life sciences industry should pay close attention to this case, too.
https://www.agencyiq.com/blog/e-cigarette-lawsuit-may-imperil-fdas-regulation-of-medical-products/
But as I explained in early September, the life sciences industry should pay close attention to this case, too.
https://www.agencyiq.com/blog/e-cigarette-lawsuit-may-imperil-fdas-regulation-of-medical-products/
Comments
Guidance documents are non-binding documents commonly used by FDA to guide the development of regulated products.
If SCOTUS says FDA can't change its mind, FDA might shy away from them.